Gestational diabetes promotes future maternal cardiovascular disease through endothelin activation and suppressed NO/cGMP/PRKG and AMPK/SIRT1 signaling pathways.
- DOI
- 10.1152/ajpheart.00871.2025
- Published
- 2026 Sep 1
- Container
- American journal of physiology. Heart and circulatory physiology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1152/ajpheart.00871.2025,
title = {Gestational diabetes promotes future maternal cardiovascular disease through endothelin activation and suppressed NO/cGMP/PRKG and AMPK/SIRT1 signaling pathways.},
author = {Badmus OO and Wahba S and Arthur G and Parrow LD and Montgomery BS and Cucolicchio I and McGowan K and Taylor EB},
year = {2026},
journal = {American journal of physiology. Heart and circulatory physiology},
doi = {10.1152/ajpheart.00871.2025},
url = {https://doi.org/10.1152/ajpheart.00871.2025}
}RIS
TY - JOUR TI - Gestational diabetes promotes future maternal cardiovascular disease through endothelin activation and suppressed NO/cGMP/PRKG and AMPK/SIRT1 signaling pathways. AU - Badmus OO AU - Wahba S AU - Arthur G AU - Parrow LD AU - Montgomery BS AU - Cucolicchio I AU - McGowan K AU - Taylor EB PY - 2026 JO - American journal of physiology. Heart and circulatory physiology DO - 10.1152/ajpheart.00871.2025 UR - https://doi.org/10.1152/ajpheart.00871.2025 ER -
APA
OO, B., S, W., G, A., LD, P., BS, M., I, C., K, M., & EB, T. (2026). Gestational diabetes promotes future maternal cardiovascular disease through endothelin activation and suppressed NO/cGMP/PRKG and AMPK/SIRT1 signaling pathways.. American journal of physiology. Heart and circulatory physiology. https://doi.org/10.1152/ajpheart.00871.2025
Source records
- pubmed · retrieved 2026-09-27T00:36:40.329Z
- europe-pmc · retrieved 2026-09-27T00:36:40.338Z